Skip to main content
Log in

Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

The aim of this study was to establish cardiac damage related to nocturnal ischemia using heart type fatty acid binding protein (h-fabp), which reaches detectable levels in plasma after being released from myocytes in case of ischemia in obstructive sleep apnea syndrome (OSAS) patients without coronary artery disease (CAD). Fifty patients diagnosed with OSAS in our sleep laboratory with polysomnographic analysis (PSG), who did not have any previous history of cardiac disease and in whom CAD was ruled out with myocardium perfusion scintigraphy, were included in the study. Control group comprised 19 volunteers without history of cardiac disease and risk factors in whom OSAS was excluded with PSG analysis. Blood samples were drawn from the patients to examine h-fabp, creatine kinase (CK), creatine kinase-MB (CK-MB), aspartate aminotransferase (AST), troponin I levels before and after sleep. No significant difference was found in CK, CK-MB, AST, Troponin I, and h-fabp levels before and after sleep in patient and control groups (p > 0.05). No significant difference was found between groups in terms of CK, CK-MB, AST, and Troponin I levels before and after sleep, while a significant difference was found between them with regard to h-fabp levels before (p = 0.006) and after sleep (p = 0.022). When arithmetical mean of the fabp levels before and after sleep was taken in the patient group, it was found that mean value of h-fabp was associated with the desaturated period in sleep which was under 80% (p = 0.04). H-fabp seems to be a marker that will enable the detection of cardiac injury in the early asymptomatic period in OSAS patients before development of disease that can be detected by imaging methods. Further studies are required to investigate the relation between the value of h-fabp and the development of cardiac dysfunction in the long term.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Young T, Palta M, Dempsey J et al (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235

    Article  PubMed  CAS  Google Scholar 

  2. Lattimore J-DL, Celermajer DS, Wilcox I (2003) Obstructive sleep apnea and cardiovascular disease. J Am Coll Health 41:1429–1437

    Google Scholar 

  3. McNicholas WT, Bonsignore MR (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29(1):156–178 (Jan)

    Article  PubMed  CAS  Google Scholar 

  4. Marin JM, Carrizo SJ et al (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053 (Mar 19–25)

    PubMed  Google Scholar 

  5. Parish JM, Somers VK (2004) Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 79(8):1036–1046 (August)

    PubMed  Google Scholar 

  6. Andreas S, Schultz R, Werner GS, Kreuzer H (1996) Prevalence of obstructive sleep apnea in patients with coronary artery disease. Coron Artery Dis 7:541–545

    Article  PubMed  CAS  Google Scholar 

  7. Peled N, Abinader EG, Pillar G, Sharif D, Lavie P (1999) Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol 34(6):1744–1749 (Nov 15)

    Article  PubMed  CAS  Google Scholar 

  8. Hanly P, Sasson Z et al (1993) ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71(15):1341–1345

    Article  PubMed  CAS  Google Scholar 

  9. Alhadi HA, Fox KA (2004) Do we need additional markers of myocyte necrosis: the potential value of heart fatty acid binding protein. Q J Med 97:187–198

    CAS  Google Scholar 

  10. Nakata T et al (2003) Human Heart type fatty acid binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 99:96–104

    Article  PubMed  CAS  Google Scholar 

  11. Schafer H, Koehier U, Ploch T et al (1997) Sleep related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 111:387–393

    Article  PubMed  CAS  Google Scholar 

  12. Alonso-Fernández A, García-Río F et al (2005) Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea–hypopnea syndrome and its mechanisms. Chest 127:15–22

    Article  PubMed  Google Scholar 

  13. Andreas S, Hajak G, Natt P et al (1991) ST segmental changes and arrhythmias in obstructive sleep apnea. Pneumologie 45(9):720–724

    PubMed  CAS  Google Scholar 

  14. Hanly P, Sasson Z, Zuberi N et al (1993) ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71:1341–1345

    Article  PubMed  CAS  Google Scholar 

  15. Franklin KA, Nilsson JB, Sahlin C et al (1995) Sleep apnoea and nocturnal angina. Lancet 345:1085–1087

    Article  PubMed  CAS  Google Scholar 

  16. Gami AS, Svatikova A, Wolk R et al (2004) Cardiac troponin T in obstructive sleep apnea. Chest 125(6):2097–2100

    Article  PubMed  CAS  Google Scholar 

  17. Pepin JL, Levy P (2002) Pathophysiology of cardiovascular risk in sleep apnea syndrome (SAS). Rev Neurol (Paris) 158(8–9):785–797

    CAS  Google Scholar 

  18. Narkiewicz K, Somers VK (2003) Sympathetic nerve activity in obstructive sleep apnea. Acta Physiol Scand 177:385–390

    Article  PubMed  CAS  Google Scholar 

  19. Somers VK, Dyken ME, Clary MP, Abboud FM (1995) Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897–904

    Article  PubMed  CAS  Google Scholar 

  20. Aydin M, Altin R (2004) Cardiac autonomic activity in obstructive sleep apnea. Tex Heart Inst J 31(2):132–136

    PubMed  Google Scholar 

  21. Noda A, Ito R, Okada T et al (1998) Twenty-four-hour ambulatory oxygen desaturation and electrocardiographic recording in obstructive sleep apnea syndrome. Clin Cardiol 21(7):506–510 (Jul)

    PubMed  CAS  Google Scholar 

  22. Yoshimoto K, Tanaka T, Somiya K et al (1995) Human heart-type cytoplasmic fatty acid-binding protein as an indicator of acute myocardial infarction. Heart Vessels 10:304–309

    Article  PubMed  CAS  Google Scholar 

  23. Zschiesche W, Kleine AH, Spitzer E, Veerkamp JH, Glatz JF (1995) Histochemical localization of heart-type fatty acid-binding protein in human and murine tissues. Histochem Cell Biol 103:147–156

    Article  PubMed  CAS  Google Scholar 

  24. Azzazy HME, Pelsers MMAL, Christenson RH (2006) Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications. Clin Chem 52:19–29

    Article  PubMed  CAS  Google Scholar 

  25. Gorski J, Hermens WT, Borawski J, Mysliwiec M, Glatz JF (1997) Increased fatty acid-binding protein concentration in plasma of patients with chronic renal failure. Clin Chem 43:193–195

    PubMed  CAS  Google Scholar 

  26. Tanaka T, Hirota Y, Sohmiya K, Nishimura S, Kawamura K (1991) Serum and urinary human heart fatty acid-binding protein in acute myocardial infarction. Clin Biochem 24:195–201

    Article  PubMed  CAS  Google Scholar 

  27. Wodzig KW, Pelsers MM, Van der Vusse GJ, Roos W, Glatz JF (1997) One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem 34:263–268

    PubMed  CAS  Google Scholar 

  28. Tsuji R, Tanaka T, Sohmiya K et al (1993) Human heart-type cytoplasmic fatty acid-binding protein in serum and urine during hyperacute myocardial infarction. Int J Cardiol 41:209–217

    Article  PubMed  CAS  Google Scholar 

  29. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ (1992) Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 116:155–162

    Article  PubMed  CAS  Google Scholar 

  30. Ohkura Y, Asamaya K, Ishii H et al (1995) Development of sandwich enzyme-linked immunosorbent assay fort he determination of human heart type fatty acid-binding protein in plazma and urine by using two different monoclonal antibodies specific for human heart fatty acid binding protein. J Immunol Methods 178:99–111

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Burcu Oktay.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oktay, B., Akbal, E., Firat, H. et al. Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome. Sleep Breath 12, 223–228 (2008). https://doi.org/10.1007/s11325-007-0167-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-007-0167-1

Keywords

Navigation